Cardiac fibrosis and diastolic dysfunction after myocardial infarction in apolipoprotein e knockout mice

Coronary Artery Disease

Volumn 20, Issue 7, 2009, Pages 479-482

  French, Christopher J ^a   Zaman, A K M Tarikuz ^a   Sobel, Burton E ^a  

^a University of Vermont Colchester Research Facility   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HYDROXYPROLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BODY WEIGHT; CONTROLLED STUDY; DIASTOLE; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; EDITORIAL; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HISTOLOGY; IN VIVO STUDY; KNOCKOUT MOUSE; LIPID METABOLISM; M MODE ECHOCARDIOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; APOLIPOPROTEINS E; BODY WEIGHT; DIASTOLE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER; FIBROSIS; GENOTYPE; HYDROXYPROLINE; HYPERCHOLESTEROLEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; PHENOTYPE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 70350776602     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283319b6c     Document Type: Editorial

References (16)

1. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71:343-353.
2. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258:468-471.
3. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14:133-140.
4. Nievelstein PF, Fogelman AM, Mottino G, Frank JS. Lipid accumulation in rabbit aortic intima 2 h after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler Thromb 1991; 11:1795-1805.
5. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994; 14:141-147.
6. Tamminen M, Mottino G, Qiao JH, Breslow JL, Frank JS. Ultrastructure of early lipid accumulation in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19:847-853.
7. Zaman AK, Fujii S, Schneider DJ, Taatjes DJ, Lijnen HR, Sobel BE. Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants. Histochem Cell Biol 2007; 128:135-145.
8. Zaman AK, French CJ, Schneider DJ, Sobel BE. A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart. Exp Biol Med 2009; 234:246-254.
9. Ignat'eva NY, Danilov NA, Averkiev SV, Obrezkova MV, Lunin VV, Sobol EN. Determination of hydroxyproline in tissues and the evaluation of the collagen content of the tissues. J Anal Chem 2007; 62:51-57.
10. Wei S, Chow LT, Shum IO, Qin L, Sanderson JE. Left and right ventricular collagen type I/III ratios and remodeling post-myocardial infarction. J Card Fail 1999; 5:117-126.
11. Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967; 19:249-255.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
13. French CJ, Zaman AK, Sobel BE. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion. Coron Artery Dis 2009; 20:295-299.
14. Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002; 105:868-873. (Pubitemid 34174929)
15. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121:951-957.
16. Kjekshus J, Pedersen TR, Olsson AG, Faergeman O, Pyorala K. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail 1997; 3:249-254. (Pubitemid 127674856)